In vivo studies verified that treatment with ginsenoside CK not only inhibited tumor growth (reduced tumor volume and weight) but also suppressed the local EMT process resulting from the regulation of HIF-1α/NF-κB signaling. This evidence concerns the gene HIF1A and neoplasm.